B
Beta Bionics, Inc.
BBNX · NASDAQ · Healthcare · 790M
Price · close
$19.05
-2.21% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.7×
Enterprise value / EBITDAEV/EBITDA
-10.6×
Free cash flow yieldFCF yield
-7.3%
Return on equityROE
-25.5%
Operating margin
-71.5%
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.